Diagnostics
-
BD strikes supply chain pact with Trump administration
BD plans to increase U.S. production of essential medical consumables in exchange for relief from future tariffs on its products.
By Susan Kelly • Oct. 6, 2026 -
GE HealthCare to acquire Sofie Biosciences for $945M
Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging.
By Susan Kelly • Oct. 5, 2026 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
ARPA-H awards more than $100M to biosensor development projects
Four organizations will develop devices for tracking heart disease, inflammation and perimenopause.
By Nick Paul Taylor • Oct. 5, 2026 -
Sponsored by Veeva MedTech
Thermo Fisher Scientific accelerates market access by prioritizing the right KOLs
Thermo Fisher turned fragmented KOL data into real-time market demand. Read how.
Oct. 5, 2026 -
FDA to prioritize guidance on AI, surgical robots next year
The FDA outlined its A-list and B-list guidance priorities for the 2027 fiscal year.
By Nick Paul Taylor • Oct. 2, 2026 -
Abbott launches Freenome’s colorectal cancer screening test
Abbott will sell Freenome’s SimpleScreen CRC test in the U.S. alongside the Cologuard Plus stool-based test it gained in the $21 billion acquisition of Exact Sciences.
By Susan Kelly • Sept. 30, 2026 -
Lab test providers want Medicare payment reform. Will Congress pass it?
Facing maximum Medicare payment cuts, test providers Quest Diagnostics and Labcorp are urging lawmakers to revamp the rate-setting process, but getting a bill through Congress this year will be a challenge.
By Susan Kelly • Sept. 25, 2026 -
Grail multicancer detection test wins FDA advisers’ backing
Members of the molecular and clinical genetics panel said the first-of-a-kind blood test should not be used to replace medical guideline-recommended cancer screenings.
By Susan Kelly • Sept. 24, 2026 -
CMS sets preliminary cuts to Medicare lab reimbursement rates
The American Clinical Laboratory Association warned the steep annual payment cuts threaten patient access to critical lab testing services.
By Susan Kelly • Sept. 22, 2026 -
Mayo Clinic, Thermo Fisher partner to create Precure
The company will generate population-scale molecular data to inform development of diagnostics, therapies and other healthcare products.
By Nick Paul Taylor • Sept. 21, 2026 -
Neptune Medical secures FDA nod for endoscopy robot
The robot is intended to give physicians more control of the endoscope during a colonoscopy procedure, which can help with detection and removal of lesions.
By Susan Kelly • Sept. 18, 2026 -
Labcorp acquires MLM Medical Labs in global expansion
Buying MLM gives Labcorp a wholly owned laboratory network that spans North America, Europe, Asia and Africa.
By Nick Paul Taylor • Sept. 9, 2026 -
Retrieved from Elucid on September 08, 2026
Elucid raises $55M to commercialize cardiovascular imaging platform
Elucid, which gained a large medtech company as an investor, plans to grow industry partnerships as it looks to expand its AI-powered imaging platform.
By Nick Paul Taylor • Sept. 8, 2026 -
GE HealthCare secures CE mark for photon-counting CT device
GE HealthCare is challenging Siemens Healthineers in the market for a technology that is designed to provide clearer images than traditional CT systems.
By Nick Paul Taylor • Sept. 1, 2026 -
Cleveland Diagnostics hires new CFO
Valerie Dixon arrives at Cleveland Diagnostics as the company works to commercialize its prostate cancer test in the U.S.
By Nick Paul Taylor • Aug. 27, 2026 -
Guardant Health ordered to pay $245M in patent dispute
A U.S. court ruled Guardant willfully infringed two core patents for DNA sequencing methods in a case brought by TwinStrand Biosciences and the University of Washington.
By Susan Kelly • Aug. 26, 2026 -
Qiagen names new CEO
Jonathan Pratt will take over the role on Sept. 1. The announcement ends Qiagen’s nearly 10-month search for a new chief executive.
By Nick Paul Taylor • Aug. 25, 2026 -
National Institute on Aging. (2017). "Beta-Amyloid Plaques and Tau in the Brain" [Image]. Retrieved from Flickr.
Roche, Eli Lilly get FDA nod for new Alzheimer’s blood test
Labcorp and Quest Diagnostics both plan to offer the test, which secured CE mark certification earlier this year.
By Susan Kelly • Aug. 25, 2026 -
Q&A
How Guardant aims to expand cancer screening with a blood test
Sam Asgarian, Guardant Health’s vice president of clinical development, discusses the progress and challenges of blood-based testing in colorectal and multicancer screening.
By Susan Kelly • Aug. 18, 2026 -
Baylor Genetics discloses patient information exposed in cyberattack
A third party may have accessed test results and Social Security numbers held by the genetic testing company.
By Nick Paul Taylor • Aug. 18, 2026 -
J&J’s Monarch robot wins FDA nod for AI features
The lung bronchoscopy robot adds improvements that include new tools for pre-procedure planning and updated navigation and visual guidance during the procedure.
By Susan Kelly • Aug. 17, 2026 -
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm
European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.
By Susan Kelly • Aug. 13, 2026 -
FDA sets advisory panel for Galleri multicancer screening test
Outside experts will convene in September to review Grail’s premarket approval application for the MCED blood test. Experts selected for the committee will be key to watch, an analyst said.
By Susan Kelly • Aug. 7, 2026 -
Danaher promotes Julie Sawyer Montgomery to CEO
The executive has led Danaher’s diagnostics business, where she helped triple operating profit during her tenure and oversaw the recent acquisition of Masimo.
By Susan Kelly • Aug. 4, 2026 -
Siemens Healthineers names new head of the Americas
The company disclosed the appointment of João Seabra the day before cutting its full-year sales outlook in response to continued challenges at its diagnostics division.
By Nick Paul Taylor • Aug. 3, 2026